Plain-English translation of NCT06890312 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
During a heart catheter procedure performed through the wrist, doctors use a medication called heparin (a blood thinner) to prevent complications. This trial is testing whether giving heparin before the catheter tube is inserted works better than giving it after insertion, which is the current standard practice.
One serious complication of wrist-based heart procedures is that the artery can become blocked after the procedure. While doctors know that blood thinners help prevent this, no one has studied whether the timing of when the medication is given makes a difference in preventing this complication.
You likely qualify if…
You likely don't qualify if…
You will undergo your scheduled heart catheter procedure through the wrist artery. The only difference from standard care is the timing of when you receive the blood thinner medication: one group receives it before the catheter tube is inserted, while the other group receives it after insertion (current standard). You will be randomly assigned to one of these two groups, and doctors will monitor you during and after the procedure to watch for any complications.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
France